IDYA•benzinga•
IDEAYA Biosciences Receives Orphan Drug Designation For Darovasertib, A PKC Inhibitor, For The Treatment of Uveal Melanoma
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga